Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Le cluster Albendazole (therapeutic use) - Ivermectin (therapeutic use)

Terms

15Albendazole (therapeutic use)
16Ivermectin (therapeutic use)
60Elephantiasis, Filarial (drug therapy)
39Filaricides (therapeutic use)
69Elephantiasis, Filarial (prevention & control)
80Elephantiasis, Filarial (epidemiology)
67Prevalence
11Onchocerciasis (drug therapy)

Associations

Freq.WeightAssociation
130.839Albendazole (therapeutic use) - Ivermectin (therapeutic use)
270.558Elephantiasis, Filarial (drug therapy) - Filaricides (therapeutic use)
290.451Elephantiasis, Filarial (drug therapy) - Elephantiasis, Filarial (prevention & control)
390.533Elephantiasis, Filarial (epidemiology) - Prevalence
330.444Elephantiasis, Filarial (epidemiology) - Elephantiasis, Filarial (prevention & control)
230.443Elephantiasis, Filarial (prevention & control) - Filaricides (therapeutic use)
110.440Filaricides (therapeutic use) - Ivermectin (therapeutic use)
130.433Albendazole (therapeutic use) - Elephantiasis, Filarial (drug therapy)
110.428Elephantiasis, Filarial (drug therapy) - Onchocerciasis (drug therapy)
100.413Albendazole (therapeutic use) - Filaricides (therapeutic use)
120.387Elephantiasis, Filarial (drug therapy) - Ivermectin (therapeutic use)
120.361Elephantiasis, Filarial (prevention & control) - Ivermectin (therapeutic use)
240.346Elephantiasis, Filarial (drug therapy) - Elephantiasis, Filarial (epidemiology)
110.342Albendazole (therapeutic use) - Elephantiasis, Filarial (prevention & control)
160.286Elephantiasis, Filarial (epidemiology) - Filaricides (therapeutic use)
150.221Elephantiasis, Filarial (prevention & control) - Prevalence
130.205Elephantiasis, Filarial (drug therapy) - Prevalence
90.176Filaricides (therapeutic use) - Prevalence

Documents par ordre de pertinence
000720 (2010) Mark J. Taylor [Royaume-Uni] ; Achim Hoerauf ; Moses BockarieLymphatic filariasis and onchocerciasis.
000020 (2017) Lassane Koala [Burkina Faso] ; Achille Nikiema [Burkina Faso] ; Rory J. Post [Royaume-Uni] ; Alain Brice Paré [Burkina Faso] ; Claude Montant Kafando [Burkina Faso] ; François Drabo [Burkina Faso] ; Soungalo Traoré [Burkina Faso]Recrudescence of onchocerciasis in the Comoé valley in Southwest Burkina Faso.
000C63 (2003) David H. Molyneux [Royaume-Uni] ; Mark Bradley ; Achim Hoerauf ; Dominique Kyelem ; Mark J. TaylorMass drug treatment for lymphatic filariasis and onchocerciasis.
000127 (2016) Alison Krentel [Royaume-Uni] ; Rita Damayanti [Indonésie] ; Christiana Rialine Titaley [Indonésie] ; Nugroho Suharno [Indonésie] ; Mark Bradley [Royaume-Uni] ; Timothy Lynam [Australie]Improving Coverage and Compliance in Mass Drug Administration for the Elimination of LF in Two 'Endgame' Districts in Indonesia Using Micronarrative Surveys.
000361 (2013) Maria P. Rebollo [Royaume-Uni] ; Moses J. BockarieToward the elimination of lymphatic filariasis by 2020: treatment update and impact assessment for the endgame.
000797 (2009) J. Horton [Royaume-Uni]The development of albendazole for lymphatic filariasis.
000827 (2009) David H. Molyneux [Royaume-Uni]Filaria control and elimination: diagnostic, monitoring and surveillance needs.
000A58 (2006) Edwin Michael [Royaume-Uni] ; Mwele N. Malecela-Lazaro ; Conrad Kabali ; Lucy C. Snow ; James W. KazuraMathematical models and lymphatic filariasis control: endpoints and optimal interventions.
000B26 (2005) D. Kyelem [Royaume-Uni] ; J. Medlock ; S. Sanou ; M. Bonkoungou ; B. Boatin ; D H MolyneuxShort communication: impact of long-term (14 years) bi-annual ivermectin treatment on Wuchereria bancrofti microfilaraemia.
000B44 (2005) Julia Critchley [Royaume-Uni] ; David Addiss ; Henry Ejere ; Carrol Gamble ; Paul Garner ; Hellen GelbandAlbendazole for the control and elimination of lymphatic filariasis: systematic review.
000B82 (2004) Edwin Michael [Royaume-Uni] ; Mwele N. Malecela-Lazaro ; Paul E. Simonsen ; Erling M. Pedersen ; Guy Barker ; Anil Kumar ; James W. KazuraMathematical modelling and the control of lymphatic filariasis.
000D21 (2002) C F Curtis [Royaume-Uni] ; M. Malecela-Lazaro ; R. Reuben ; C A MaxwellUse of floating layers of polystyrene beads to control populations of the filaria vector Culex quinquefasciatus.
000D26 (2002) D H Molyneux [Royaume-Uni] ; N. ZagariaLymphatic filariasis elimination: progress in global programme development.
000E79 (2000) J. Horton [Royaume-Uni] ; C. Witt ; E A Ottesen ; J K Lazdins ; D G Addiss ; K. Awadzi ; M J Beach ; V Y Belizario ; S K Dunyo ; M. Espinel ; J O Gyapong ; M. Hossain ; M M Ismail ; R L Jayakody ; P J Lammie ; W. Makunde ; D. Richard-Lenoble ; B. Selve ; R K Shenoy ; P E Simonsen ; C N Wamae ; M V WeerasooriyaAn analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis.
001107 (1998) Dan Wolf Meyrowitsch [Danemark] ; Nguyen Duy Toan [Viêt Nam] ; Hoang Thi Hao [Viêt Nam] ; Nguyen The Dan [Viêt Nam] ; Edwin Michael [Royaume-Uni]A review of the present status of lymphatic filariasis in Vietnam
000278 (2014) Maria P. Rebollo [Royaume-Uni] ; Moses John Bockarie [Royaume-Uni]Shrinking the lymphatic filariasis map: update on diagnostic tools for mapping and transmission monitoring.
000341 (2014) Pamela J. Hooper [États-Unis] ; Brian K. Chu [États-Unis] ; Alexei Mikhailov [Suisse] ; Eric A. Ottesen [États-Unis] ; Mark Bradley [Royaume-Uni]Assessing Progress in Reducing the At-Risk Population after 13 Years of the Global Programme to Eliminate Lymphatic Filariasis
000389 (2013) Patricia N. Okorie [Nigeria] ; George O. Ademowo [Nigeria] ; Yisa Saka [Nigeria] ; Emmanuel Davies [Nigeria] ; Chukwu Okoronkwo [Nigeria] ; Moses J. Bockarie [Royaume-Uni] ; David H. Molyneux [Royaume-Uni] ; Louise A. Kelly-Hope [Royaume-Uni]Lymphatic Filariasis in Nigeria; Micro-stratification Overlap Mapping (MOM) as a Prerequisite for Cost-Effective Resource Utilization in Control and Surveillance
000395 (2013) Joseph B. Koroma [Sierra Leone, Burkina Faso, Royaume-Uni] ; Santigie Sesay [Sierra Leone] ; Mustapha Sonnie [Sierra Leone] ; Mary H. Hodges [Sierra Leone] ; Foday Sahr [Sierra Leone] ; Yaobi Zhang [Sénégal] ; Moses J. Bockarie [Royaume-Uni]Impact of Three Rounds of Mass Drug Administration on Lymphatic Filariasis in Areas Previously Treated for Onchocerciasis in Sierra Leone
000424 (2013) Yaya Ibrahim Coulibaly [Mali] ; Ilo Dicko [Mali] ; Modibo Keita [Mali] ; Mahamadou Minamba Keita [Mali] ; Moussa Doumbia [Mali] ; Adama Daou [Mali] ; Fadima Cheick Haidara [Mali] ; Moussa Hama Sankare [Mali] ; John Horton [Royaume-Uni] ; Caroline Whately-Smith [Royaume-Uni] ; Samba Ousmane Sow [Mali]A Cluster Randomized Study of The Safety of Integrated Treatment of Trachoma and Lymphatic Filariasis in Children and Adults in Sikasso, Mali
000494 (2012) Khalfan A. Mohammed ; Rinki M. Deb [Royaume-Uni] ; Michelle C. Stanton [Royaume-Uni] ; David H. Molyneux [Royaume-Uni]Soil transmitted helminths and scabies in Zanzibar, Tanzania following mass drug administration for lymphatic filariasis - a rapid assessment methodology to assess impact
000708 (2010) Brian K. Chu [États-Unis] ; Pamela J. Hooper [États-Unis] ; Mark H. Bradley [Royaume-Uni] ; Deborah A. Mcfarland [États-Unis] ; Eric A. Ottesen [États-Unis]The Economic Benefits Resulting from the First 8 Years of the Global Programme to Eliminate Lymphatic Filariasis (2000–2007)
000732 (2010) Manoj Gambhir [Royaume-Uni] ; Moses Bockarie [Royaume-Uni] ; Daniel Tisch [États-Unis] ; James Kazura [États-Unis] ; Justin Remais [États-Unis] ; Robert Spear [États-Unis] ; Edwin Michael [Royaume-Uni]Geographic and ecologic heterogeneity in elimination thresholds for the major vector-borne helminthic disease, lymphatic filariasis
000841 (2009) David H. Molyneux [Royaume-Uni]10 years of success in addressing lymphatic filariasis.
000890 (2008) Khalfan A. Mohammed [Royaume-Uni] ; Hamad J. Haji ; Albis-Francesco Gabrielli [Suisse] ; Likezo Mubila [Zimbabwe] ; Gautam Biswas [Suisse] ; Lester Chitsulo [Suisse] ; Mark H. Bradley [Royaume-Uni] ; Dirk Engels [Suisse] ; Lorenzo Savioli [Suisse] ; David H. Molyneux [Royaume-Uni]Triple Co-Administration of Ivermectin, Albendazole and Praziquantel in Zanzibar: A Safety Study
000908 (2008) Edwin Michael [Royaume-Uni] ; Mwele N. Malecela [Tanzanie] ; Mihail Zervos [Royaume-Uni] ; James W. Kazura [États-Unis]Global Eradication of Lymphatic Filariasis: The Value of Chronic Disease Control in Parasite Elimination Programmes
000957 (2007) Shona Wynd [Royaume-Uni, Australie] ; Wayne D. Melrose [Australie] ; David N. Durrheim [Australie] ; Jaime Carron [Canada] ; Margaret Gyapong [Ghana]Understanding the community impact of lymphatic filariasis: a review of the sociocultural literature
000A63 (2006) David H. Molyneux [Royaume-Uni]Elimination of transmission of lymphatic filariasis in Egypt.
000B45 (2005) Julia Critchley [Royaume-Uni] ; D. Addiss ; C. Gamble ; P. Garner ; H. Gelband ; H. EjereAlbendazole for lymphatic filariasis.
000088 (2016) Michael A. Irvine [Royaume-Uni] ; Sammy M. Njenga [Kenya] ; Shamini Gunawardena [Kenya] ; Claire Njeri Wamae [Kenya] ; Jorge Cano [Royaume-Uni] ; Simon J. Brooker [Royaume-Uni] ; T. Deirdre Hollingsworth [Royaume-Uni]Understanding the relationship between prevalence of microfilariae and antigenaemia using a model of lymphatic filariasis infection
000100 (2016) Moses J. Bockarie [Royaume-Uni] ; Maria P. Rebollo [Espagne]Reducing the population requiring interventions against lymphatic filariasis in Africa.
000138 (2016) Belete Mengitsu [Éthiopie] ; Oumer Shafi [États-Unis] ; Biruck Kebede [Éthiopie] ; Fikreab Kebede [Éthiopie] ; Dagemlidet T. Worku [Éthiopie] ; Merce Herero [Éthiopie] ; Michael French [Éthiopie] ; Biruk Kebede [Éthiopie] ; Charles Mackenzie [Royaume-Uni] ; Sarah Martindale [Royaume-Uni] ; Zeyede Kebede [Éthiopie] ; Tigist Hirpa [Éthiopie] ; Hannah Frawley [États-Unis] ; Kathryn Crowley [États-Unis] ; Maggie O'Neil [États-Unis] ; Scott McphersonEthiopia and its steps to mobilize resources to achieve 2020 elimination and control goals for neglected tropical diseases webs joined can tie a lion.
000198 (2015) M. A. Irvine [Royaume-Uni] ; L. J. Reimer ; S. M. Njenga [Kenya] ; S. Gunawardena [Sri Lanka] ; L. Kelly-Hope ; M. Bockarie ; T. D. Hollingsworth [Royaume-Uni]Modelling strategies to break transmission of lymphatic filariasis - aggregation, adherence and vector competence greatly alter elimination
000241 (2015) Israt Hafiz [Royaume-Uni] ; Patricia Graves [Australie] ; Rouseli Haq [Bangladesh] ; Meerjady Sabrina Flora [Bangladesh] ; Louise A. Kelly-Hope [Royaume-Uni]Clinical case estimates of lymphatic filariasis in an endemic district of Bangladesh after a decade of mass drug administration.
000296 (2014) Kelly L. Johnston [Royaume-Uni] ; Louise Ford ; Mark J. TaylorOvercoming the challenges of drug discovery for neglected tropical diseases: the A·WOL experience.
000370 (2013) Brajendra K. Singh [États-Unis] ; Moses J. Bockarie [Royaume-Uni] ; Manoj Gambhir [Royaume-Uni] ; Peter M. Siba [Papouasie-Nouvelle-Guinée] ; Daniel J. Tisch [États-Unis] ; James Kazura [États-Unis] ; Edwin Michael [États-Unis]Sequential Modelling of the Effects of Mass Drug Treatments on Anopheline-Mediated Lymphatic Filariasis Infection in Papua New Guinea
000423 (2013) Alison Krentel [États-Unis, Royaume-Uni] ; Peter U. Fischer [États-Unis] ; Gary J. Weil [États-Unis]A Review of Factors That Influence Individual Compliance with Mass Drug Administration for Elimination of Lymphatic Filariasis
000486 (2012) Melissa Parker [Royaume-Uni] ; Tim Allen [Royaume-Uni]WILL MASS DRUG ADMINISTRATION ELIMINATE LYMPHATIC FILARIASIS? EVIDENCE FROM NORTHERN COASTAL TANZANIA
000488 (2012) David H. Molyneux [Royaume-Uni]Tropical lymphedemas--control and prevention.
000548 (2012) Katherine Gass [États-Unis] ; Madsen V. E. Beau De Rochars [Haïti] ; Daniel Boakye [Ghana] ; Mark Bradley [Royaume-Uni] ; Peter U. Fischer [États-Unis] ; John Gyapong [Ghana] ; Makoto Itoh [Japon] ; Nese Ituaso-Conway [Tuvalu] ; Hayley Joseph [Australie] ; Dominique Kyelem [États-Unis] ; Sandra J. Laney [États-Unis] ; Anne-Marie Legrand [Polynésie française] ; Tilaka S. Liyanage [Sri Lanka] ; Wayne Melrose [Australie] ; Khalfan Mohammed ; Nils Pilotte [États-Unis] ; Eric A. Ottesen [États-Unis] ; Catherine Plichart [Polynésie française] ; Kapa Ramaiah [Inde] ; Ramakrishna U. Rao [États-Unis] ; Jeffrey Talbot [États-Unis] ; Gary J. Weil [États-Unis] ; Steven A. Williams [États-Unis] ; Kimberly Y. Won [États-Unis] ; Patrick Lammie [États-Unis]A Multicenter Evaluation of Diagnostic Tools to Define Endpoints for Programs to Eliminate Bancroftian Filariasis
000602 (2011) Sammy M. Njenga [Kenya] ; Charles S. Mwandawiro [Kenya] ; C Njeri Wamae [Kenya] ; Dunstan A. Mukoko [Kenya] ; Anisa A. Omar [Kenya] ; Masaaki Shimada [Kenya, Japon] ; Moses J. Bockarie [Royaume-Uni] ; David H. Molyneux [Royaume-Uni]Sustained reduction in prevalence of lymphatic filariasis infection in spite of missed rounds of mass drug administration in an area under mosquito nets for malaria control
000605 (2011) Daniel J. Tisch [États-Unis] ; Neal D. E. Alexander [Papouasie-Nouvelle-Guinée, Royaume-Uni] ; Benson Kiniboro [Papouasie-Nouvelle-Guinée] ; Henry Dagoro [Papouasie-Nouvelle-Guinée] ; Peter M. Siba [Papouasie-Nouvelle-Guinée] ; Moses J. Bockarie [Papouasie-Nouvelle-Guinée, Royaume-Uni] ; Michael P. Alpers [Papouasie-Nouvelle-Guinée, Australie] ; James W. Kazura [États-Unis]Reduction in Acute Filariasis Morbidity during a Mass Drug Administration Trial to Eliminate Lymphatic Filariasis in Papua New Guinea
000796 (2009) Moses J. Bockarie [Royaume-Uni] ; David H. MolyneuxThe end of lymphatic filariasis?
000831 (2009) Moses J. Bockarie [Royaume-Uni] ; Mark J. Taylor ; John O. GyapongCurrent practices in the management of lymphatic filariasis.
000895 (2008) Eric A. Ottesen [États-Unis] ; Pamela J. Hooper [États-Unis] ; Mark Bradley [Royaume-Uni] ; Gautam Biswas [Suisse]The Global Programme to Eliminate Lymphatic Filariasis: Health Impact after 8 Years
000979 (2007) Edwin Michael [Royaume-Uni] ; Mwele N. Malecela-Lazaro ; James W. KazuraEpidemiological modelling for monitoring and evaluation of lymphatic filariasis control.
000A48 (2006) Louise A. Kelly-Hope [Royaume-Uni] ; Peter J. Diggle ; Barry S. Rowlingson ; John O. Gyapong ; Dominique Kyelem ; Michael Coleman ; Madeleine C. Thomson ; Valerie Obsomer ; Steve W. Lindsay ; Janet Hemingway ; David H. MolyneuxShort communication: Negative spatial association between lymphatic filariasis and malaria in West Africa.
000D51 (2002) M. J. Bockarie [Papouasie-Nouvelle-Guinée] ; L. Tavul ; W. Kastens ; E. Michael [Royaume-Uni] ; J. W. Kazura [États-Unis]Impact of untreated bednets on prevalence of Wuchereria bancrofti transmitted by Anopheles farauti in Papua New Guinea
000086 (2016) Daniela K. Schlüter [Royaume-Uni] ; Martial L. Ndeffo-Mbah [États-Unis] ; Innocent Takougang [Cameroun] ; Tony Ukety [Suisse] ; Samuel Wanji [Cameroun] ; Alison P. Galvani [États-Unis] ; Peter J. Diggle [Royaume-Uni]Using Community-Level Prevalence of Loa loa Infection to Predict the Proportion of Highly-Infected Individuals: Statistical Modelling to Support Lymphatic Filariasis and Onchocerciasis Elimination Programs.
000155 (2016) Christopher Fitzpatrick [Suisse] ; Fiona M. Fleming [Royaume-Uni] ; Matthew Madin-Warburton [Suisse] ; Timm Schneider [Allemagne] ; Filip Meheus [Afrique du Sud] ; Kingsley Asiedu [Suisse] ; Anthony W. Solomon [Suisse] ; Antonio Montresor [Suisse] ; Gautam Biswas [Suisse]Benchmarking the Cost per Person of Mass Treatment for Selected Neglected Tropical Diseases: An Approach Based on Literature Review and Meta-regression with Web-Based Software Application.
000176 (2015) Dziedzom K. De Souza [Ghana] ; Rashid Ansumana [Royaume-Uni, Sierra Leone] ; Santigie Sessay [Sierra Leone] ; Abu Conteh [Sierra Leone] ; Benjamin Koudou [Royaume-Uni] ; Maria P. Rebollo [États-Unis] ; Joseph Koroma [Royaume-Uni] ; Daniel A. Boakye [Ghana] ; Moses J. Bockarie [Royaume-Uni]The impact of residual infections on Anopheles-transmitted Wuchereria bancrofti after multiple rounds of mass drug administration
000183 (2015) Maria P. Rebollo [Royaume-Uni] ; Heven Sime [Éthiopie] ; Ashenafi Assefa [Éthiopie] ; Jorge Cano [Royaume-Uni] ; Kebede Deribe [Royaume-Uni, Éthiopie] ; Alba Gonzalez-Escalada [Espagne] ; Oumer Shafi [Éthiopie] ; Gail Davey [Royaume-Uni] ; Simon J. Brooker [Royaume-Uni] ; Amha Kebede [Éthiopie] ; Moses J. Bockarie [Royaume-Uni]Shrinking the Lymphatic Filariasis Map of Ethiopia: Reassessing the Population at Risk through Nationwide Mapping
000197 (2015) Paula Moraga [Royaume-Uni] ; Jorge Cano [Royaume-Uni] ; Rebecca F. Baggaley [Royaume-Uni] ; John O. Gyapong [Ghana] ; Sammy M. Njenga [Kenya] ; Birgit Nikolay [Royaume-Uni] ; Emmanuel Davies [Nigeria] ; Maria P. Rebollo [États-Unis] ; Rachel L. Pullan [Royaume-Uni] ; Moses J. Bockarie [Royaume-Uni] ; T. Déirdre Hollingsworth [Royaume-Uni] ; Manoj Gambhir [Australie] ; Simon J. Brooker [Royaume-Uni]Modelling the distribution and transmission intensity of lymphatic filariasis in sub-Saharan Africa prior to scaling up interventions: integrated use of geostatistical and mathematical modelling
000217 (2015) Terence Tafatatha [Malawi, Royaume-Uni] ; Miriam Taegtmeyer [Royaume-Uni] ; Bagrey Ngwira [Malawi, Royaume-Uni] ; Amos Phiri [Malawi] ; Mariot Kondowe [Malawi] ; Wilson Piston [Malawi] ; Anna Molesworth [Malawi, Royaume-Uni] ; Ndoliwe Kayuni [Malawi] ; Olivier Koole [Malawi, Royaume-Uni] ; Amelia Crampin [Malawi, Royaume-Uni] ; John Horton [Royaume-Uni] ; Neil French [Malawi, Royaume-Uni]Human Immunodeficiency Virus, Antiretroviral Therapy and Markers of Lymphatic Filariasis Infection: A Cross-sectional Study in Rural Northern Malawi
000227 (2015) Irene Offei Owusu [Ghana] ; Dziedzom K. De Souza [Ghana] ; Francis Anto [Ghana] ; Michael D. Wilson [Ghana] ; Daniel A. Boakye [Ghana] ; Moses J. Bockarie [Royaume-Uni] ; John O. Gyapong [Ghana]Evaluation of human and mosquito based diagnostic tools for defining endpoints for elimination of Anopheles transmitted lymphatic filariasis in Ghana.
000228 (2015) Maria P. Rebollo [Royaume-Uni] ; Sana Malang Sambou [Gambie] ; Brent Thomas [Royaume-Uni] ; Nana-Kwadwo Biritwum [Ghana] ; Momodou C. Jaye [Gambie] ; Louise Kelly-Hope [Royaume-Uni] ; Alba Gonzalez Escalada [Espagne] ; David H. Molyneux [Royaume-Uni] ; Moses J. Bockarie [Royaume-Uni]Elimination of Lymphatic Filariasis in The Gambia
000231 (2015) Rachel H. Clare [Royaume-Uni] ; Darren A N. Cook [Royaume-Uni] ; Kelly L. Johnston [Royaume-Uni] ; Louise Ford [Royaume-Uni] ; Stephen A. Ward [Royaume-Uni] ; Mark J. Taylor [Royaume-Uni]Development and validation of a high-throughput anti-Wolbachia whole-cell screen: a route to macrofilaricidal drugs against onchocerciasis and lymphatic filariasis.
000232 (2015) Michelle C. Stanton [Royaume-Uni] ; Square Z. Mkwanda [Malawi] ; Alexander Y. Debrah [Ghana] ; Linda Batsa [Ghana] ; Nana-Kwadwo Biritwum [Ghana] ; Achim Hoerauf [Allemagne] ; Matthew Cliffe [Royaume-Uni] ; Abigail Best [Royaume-Uni] ; Andrew Molineux [Royaume-Uni] ; Louise A. Kelly-Hope [Royaume-Uni]Developing a community-led SMS reporting tool for the rapid assessment of lymphatic filariasis morbidity burden: case studies from Malawi and Ghana
000242 (2015) Maria P. Rebollo [Royaume-Uni] ; Khalfan A. Mohammed ; Brent Thomas [Royaume-Uni] ; Shaali Ame [Tanzanie] ; Said Mohammed Ali ; Jorge Cano [Royaume-Uni] ; Alba Gonzalez Escalada [Espagne] ; Moses J. Bockarie [Royaume-Uni]Cessation of Mass Drug Administration for Lymphatic Filariasis in Zanzibar in 2006: Was Transmission Interrupted?
000250 (2015) Sören L. Becker ; Thomas Fürst [Royaume-Uni] ; David G. Addiss [États-Unis] ; Jürg Utzinger [Suisse]Assessing numbers and faces: a prerequisite for improving access to lymphatic filariasis morbidity care.
000304 (2014) David H. Molyneux ; Adrian Hopkins [États-Unis] ; Mark H. Bradley [Royaume-Uni] ; Louise A. Kelly-HopeMultidimensional complexities of filariasis control in an era of large-scale mass drug administration programmes: a can of worms
000309 (2014) Emma L. Smith [Royaume-Uni] ; Square Z. Mkwanda [Malawi] ; Sarah Martindale [Royaume-Uni] ; Louise A. Kelly-Hope [Royaume-Uni] ; Michelle C. Stanton [Royaume-Uni]Lymphatic filariasis morbidity mapping: a comprehensive examination of lymphoedema burden in Chikwawa district, Malawi.
000347 (2014) Alice Halliday [Royaume-Uni] ; Ana F. Guimaraes [Royaume-Uni] ; Hayley E. Tyrer [Royaume-Uni] ; Haelly Mejane Metuge [Cameroun] ; Chounna Ndongmo Winston Patrick [Cameroun] ; Kengne-Ouafo Jonas Arnaud [Cameroun] ; Tayong Dizzle Bita Kwenti [Cameroun] ; George Forsbrook [Royaume-Uni] ; Andrew Steven [Royaume-Uni] ; Darren Cook [Royaume-Uni] ; Peter Enyong [Cameroun] ; Samuel Wanji [Cameroun] ; Mark J. Taylor [Royaume-Uni] ; Joseph D. Turner [Royaume-Uni]A murine macrofilaricide pre-clinical screening model for onchocerciasis and lymphatic filariasis
000383 (2013) Jacqueline Leslie [Royaume-Uni] ; Amadou Garba ; Kadri Boubacar ; Youssouf Yayé ; Hannatou Sebongou ; Arouna Barkire ; Fiona M. Fleming ; Idrissa Mounkaila ; Salissou Adamou ; Maimouna Laurence B. JackouNeglected tropical diseases: comparison of the costs of integrated and vertical preventive chemotherapy treatment in Niger.
000388 (2013) Hannah Slater [Royaume-Uni] ; Edwin Michael [États-Unis]Mapping, Bayesian Geostatistical Analysis and Spatial Prediction of Lymphatic Filariasis Prevalence in Africa
000411 (2013) Louise A. Kelly-Hope [Royaume-Uni] ; David H. Molyneux [Royaume-Uni] ; Moses J. Bockarie [Royaume-Uni]Can malaria vector control accelerate the interruption of lymphatic filariasis transmission in Africa; capturing a window of opportunity?
000418 (2013) Mark J. Taylor [Royaume-Uni] ; Achim Hoerauf [Allemagne] ; Simon Townson [Royaume-Uni] ; Barton E. Slatko [États-Unis] ; Stephen A. Ward [Royaume-Uni]Anti-Wolbachia drug discovery and development: safe macrofilaricides for onchocerciasis and lymphatic filariasis
000510 (2012) Joseph B. Koroma [Sierra Leone, Royaume-Uni] ; Momodu M. Bangura [Sierra Leone] ; Mary H. Hodges [Sierra Leone] ; Mohamed S. Bah [Sierra Leone] ; Yaobi Zhang [Sénégal] ; Moses J. Bockarie [Royaume-Uni]Lymphatic filariasis mapping by Immunochromatographic Test cards and baseline microfilaria survey prior to mass drug administration in Sierra Leone
000514 (2012) Timothy P. Finn ; Barclay T. Stewart [Royaume-Uni, États-Unis] ; Heidi L. Reid [Australie] ; Nora Petty ; Anthony Sabasio ; David Oguttu [Ouganda] ; Mounir Lado ; Simon J. Brooker [Royaume-Uni, Kenya] ; Jan H. Kolaczinski [Royaume-Uni, Ouganda]Integrated Rapid Mapping of Neglected Tropical Diseases in Three States of South Sudan: Survey Findings and Treatment Needs
000525 (2012) Dziedzom K. De Souza [Ghana] ; Benjamin Koudou [Royaume-Uni] ; Louise A. Kelly-Hope [Royaume-Uni] ; Michael D. Wilson [Ghana] ; Moses J. Bockarie [Royaume-Uni] ; Daniel A. Boakye [Ghana]Diversity and transmission competence in lymphatic filariasis vectors in West Africa, and the implications for accelerated elimination of Anopheles-transmitted filariasis
000533 (2012) Alison Krentel [Royaume-Uni] ; Robert AungerCausal chain mapping: a novel method to analyse treatment compliance decisions relating to lymphatic filariasis elimination in Alor, Indonesia.
000600 (2011) Ruth A. Ashton [Ouganda, Royaume-Uni] ; Daniel J. Kyabayinze [Ouganda] ; Tom Opio [Ouganda] ; Anna Auma [Ouganda] ; Tansy Edwards [Royaume-Uni] ; Gabriel Matwale [Ouganda] ; Ambrose Onapa [Ouganda] ; Simon Brooker [Royaume-Uni, Kenya] ; Jan H. Kolaczinski [Ouganda, Royaume-Uni]The impact of mass drug administration and long-lasting insecticidal net distribution on Wuchereria bancrofti infection in humans and mosquitoes: an observational study in northern Uganda
000628 (2011) Louise A. Kelly-Hope [Royaume-Uni] ; Brent C. Thomas [Royaume-Uni] ; Moses J. Bockarie [Royaume-Uni] ; David H. Molyneux [Royaume-Uni]Lymphatic filariasis in the Democratic Republic of Congo; micro-stratification overlap mapping (MOM) as a prerequisite for control and surveillance
000703 (2010) Edwin Michael [Royaume-Uni] ; Manoj GambhirVector transmission heterogeneity and the population dynamics and control of lymphatic filariasis.
000711 (2010) Kelias Msyamboza [Malawi] ; Bagrey Ngwira [Malawi] ; Richard Banda [Malawi] ; Square Mkwanda [Malawi] ; Bernard Brabin [Royaume-Uni, Pays-Bas]Sentinel surveillance of Lymphatic filariasis, Schistosomiasis, Soil transmitted helminths and Malaria in rural southern Malawi
000734 (2010) Dziedzom De Souza [Ghana] ; Louise Kelly-Hope [Royaume-Uni] ; Bernard Lawson [Ghana] ; Michael Wilson [Ghana] ; Daniel Boakye [Ghana]Environmental Factors Associated with the Distribution of Anopheles gambiae s.s in Ghana; an Important Vector of Lymphatic Filariasis and Malaria
000735 (2010) Moses J. Bockarie [Royaume-Uni] ; Rinki M. DebElimination of lymphatic filariasis: do we have the drugs to complete the job?
000800 (2009) Fasil Tekola [Éthiopie, Royaume-Uni, États-Unis] ; Susan J. Bull [Royaume-Uni] ; Bobbie Farsides [Royaume-Uni] ; Melanie J. Newport [Royaume-Uni] ; Adebowale Adeyemo [États-Unis] ; Charles N. Rotimi [États-Unis] ; Gail Davey [Éthiopie]Tailoring Consent to Context: Designing an Appropriate Consent Process for a Biomedical Study in a Low Income Setting
000A64 (2006) Alexander Yaw Debrah [Allemagne, Ghana] ; Sabine Mand [Allemagne] ; Sabine Specht [Allemagne] ; Yeboah Marfo-Debrekyei [Ghana] ; Linda Batsa [Ghana] ; Kenneth Pfarr [Allemagne] ; John Larbi [Ghana] ; Bernard Lawson [Ghana] ; Mark Taylor [Royaume-Uni] ; Ohene Adjei [Ghana] ; Achim Hoerauf [Allemagne]Doxycycline Reduces Plasma VEGF-C/sVEGFR-3 and Improves Pathology in Lymphatic Filariasis
000D25 (2002) B M M. Ngwira [Royaume-Uni] ; C H Jabu ; H. Kanyongoloka ; M. Mponda ; A C Crampin ; K. Branson ; N D E. Alexander ; P E M. FineLymphatic filariasis in the Karonga district of northern Malawi: a prevalence survey.
000D77 (2001) M J Taylor [Royaume-Uni] ; H F Cross ; L. Ford ; W H Makunde ; G B Prasad ; K. BiloWolbachia bacteria in filarial immunity and disease.
000D78 (2001) E. Michael [Royaume-Uni] ; P E Simonsen ; M. Malecela ; W G Jaoko ; E M Pedersen ; D. Mukoko ; R T Rwegoshora ; D W MeyrowitschTransmission intensity and the immunoepidemiology of bancroftian filariasis in East Africa.
001172 (1996) E. Michael [Royaume-Uni] ; D. A. P. Bundy [Royaume-Uni] ; B. T. Grenfell [Royaume-Uni]Re-assessing the global prevalence and distribution of lymphatic filariasis
001396 (1992) B A Southgate [Royaume-Uni]Intensity and efficiency of transmission and the development of microfilaraemia and disease: their relationship in lymphatic filariasis.
001397 (1992) B T Grenfell [Royaume-Uni] ; E. MichaelInfection and disease in lymphatic filariasis: an epidemiological approach.
001440 (1991) D A Bundy [Royaume-Uni] ; B T Grenfell ; P K RajagopalanImmunoepidemiology of lymphatic filariasis: the relationship between infection and disease.
001499 (1990) D A Denham [Royaume-Uni] ; I T Midwinter ; E A FriedheimThe anthelmintic activity of a novel organic arsenical, R7/45, upon Brugia pahangi in Meriones unguiculatus.
001506 (1990) J. Surin [Royaume-Uni] ; D A DenhamComparative susceptibility to anthelmintics of Brugia pahangi in jirds infected by different methods.
001507 (1990) D A Denham [Royaume-Uni] ; I T Midwinter ; M J ShipleyBrugia pahangi adults implanted into mice: a possible screen for filaricidal activity.
001569 (1988) J N Stables [Royaume-Uni] ; G M Lees ; R. RankinThe potential of mice as animal models for antifilarial screening.
001574 (1988) J P Court [Royaume-Uni] ; J N Stables ; G M Lees ; M R Martin-Short ; R. RankinDipetalonema viteae and Brugia pahangi transplant infections in gerbils for use in antifilarial screening.
001883 (????) S W Lindsay [Royaume-Uni] ; C J ThomasMapping and estimating the population at risk from lymphatic filariasis in Africa.
001894 (????) D H Molyneux [Royaume-Uni] ; M. Neira ; B. Liese ; D. HeymannLymphatic filariasis: setting the scene for elimination.
000002 (2017) A. K. M. Shamsuzzaman [Bangladesh] ; Rouseli Haq [Bangladesh] ; Mohammad J. Karim [Bangladesh] ; Motasim B. Azad [Bangladesh] ; A. S. M. Sultan Mahmood [Bangladesh] ; Abul Khair [Bangladesh] ; Muhammad Mujibur Rahman [Bangladesh] ; Israt Hafiz [Bangladesh] ; K. D. Ramaiah [Inde] ; Charles D. Mackenzie [Royaume-Uni, États-Unis] ; Hayley E. Mableson [Royaume-Uni] ; Louise A. Kelly-Hope [Royaume-Uni]The significant scale up and success of Transmission Assessment Surveys 'TAS' for endgame surveillance of lymphatic filariasis in Bangladesh: One step closer to the elimination goal of 2020
000009 (2017) M C Stanton [Royaume-Uni]The Role of Spatial Statistics in the Control and Elimination of Neglected Tropical Diseases in Sub-Saharan Africa: A Focus on Human African Trypanosomiasis, Schistosomiasis and Lymphatic Filariasis.
000035 (2017) Upendo Mwingira [Tanzanie] ; Maria Chikawe [Tanzanie] ; Wilfred Lazarus Mandara [Tanzanie] ; Hayley E. Mableson [Royaume-Uni] ; Cecilia Uisso [Tanzanie] ; Irene Mremi [Tanzanie] ; Alpha Malishee [Tanzanie] ; Mwele Malecela [Tanzanie] ; Charles D. Mackenzie [Royaume-Uni, États-Unis] ; Louise A. Kelly-Hope [Royaume-Uni] ; Michelle C. Stanton [Royaume-Uni]Lymphatic filariasis patient identification in a large urban area of Tanzania: An application of a community-led mHealth system
000077 (2017) Sheila B. Ogoma ; Arnold S. Mmando ; Johnson K. Swai ; Sebastian Horstmann [Allemagne] ; David Malone [Royaume-Uni] ; Gerry F. KilleenA low technology emanator treated with the volatile pyrethroid transfluthrin confers long term protection against outdoor biting vectors of lymphatic filariasis, arboviruses and malaria.
000090 (2016) Hugo C. Turner [Royaume-Uni] ; Alison A. Bettis [Royaume-Uni] ; Brian K. Chu [États-Unis] ; Deborah A. Mcfarland [États-Unis] ; Pamela J. Hooper [États-Unis] ; Eric A. Ottesen [États-Unis] ; Mark H. Bradley [Royaume-Uni]The health and economic benefits of the global programme to eliminate lymphatic filariasis (2000–2014)
000102 (2016) Garry Cooper [Royaume-Uni] ; Andrew Bagnall [Royaume-Uni]Prevalence of lymphoedema in the UK: focus on the southwest and West Midlands.
000112 (2016) Raman Sharma [Royaume-Uni] ; Ghaith Al Jayoussi [Royaume-Uni] ; Hayley E. Tyrer [Royaume-Uni] ; Joanne Gamble [Royaume-Uni] ; Laura Hayward [Royaume-Uni] ; Ana F. Guimaraes [Royaume-Uni] ; Jill Davies [Royaume-Uni] ; David Waterhouse [Royaume-Uni] ; Darren A. N. Cook [Royaume-Uni] ; Laura J. Myhill [Royaume-Uni] ; Rachel H. Clare [Royaume-Uni] ; Andrew Cassidy [Royaume-Uni] ; Andrew Steven [Royaume-Uni] ; Kelly L. Johnston [Royaume-Uni] ; Louise Ford [Royaume-Uni] ; Joseph D. Turner [Royaume-Uni] ; Stephen A. Ward [Royaume-Uni] ; Mark J. Taylor [Royaume-Uni]Minocycline as a re-purposed anti-Wolbachia macrofilaricide: superiority compared with doxycycline regimens in a murine infection model of human lymphatic filariasis

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024